For more insights related to the growth of the direct-to-consumer genetic testing
market, View our Exclusive Sample Report Now
Market Dynamics
The growing adoption of direct-to-consumer genetic testing in early disease diagnosis is driving the growth of the direct-to-consumer genetic testing market. However, factors such as doubts over analytical and clinical validity may challenge the market growth during the forecast period.
Company Profiles
The direct-to-consumer genetic testing market report provides complete insights on key vendors, including 23andMe Inc., Alpha Biolaboratories Ltd., Centrillion Technology Holdings Ltd., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., and Quest Diagnostics Inc. The key offerings of some of the vendors are listed below:
- 23andMe Inc. - The company offers high-quality advanced direct-to-consumer genetic testing services.
- Alpha Biolaboratories Ltd. - The company provides a comprehensive range of direct-to-consumer genetic testing to its consumers, such as Paternity testing, Legal DNA testing, Immigration DNS testing, Aunt test, Grandparents test and others.
- Centrillion Technology Holdings Ltd. - The company offers direct-to-consumer genetic testing across the globe.
- Color Genomics Inc. - The company offers direct-to-consumer genetic testing across the globe to consumers.
- Dante Labs Inc. - The company offers its direct-to-consumer genetic testing services to its consumers.
Competitive Analysis
The competitive scenario provided in the direct-to-consumer genetic testing market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation
- By distribution channel, the market is classified into direct sales and retail sales. The direct sales segment will contribute the largest share of the market. Direct sales channels give consumers access to their personal genetic and health information, regardless of the time and place. The test orders, results, and health information are maintained on a centralized network containing personal health records. Many consumers are purchasing genetic testing services through direct sales channels, owing to the quick turnaround time in obtaining results as well as the increasing Internet penetration. This has fueled the demand for online orders of genetic tests, thus boosting revenue growth in the direct sales segment.
- By service, the market has been segmented into diagnostic screening, prenatal, newborn screening, and pre-implantation diagnosis, and relationship testing.
- By geography, the market is classified as North America, Europe, Asia, ROW, North America, Europe, Asia, and ROW. North America will have the largest share of the market.
Find out the contribution of each segment of the direct-to-consumer genetic
testing market, View our Exclusive Sample Report Now
Related Reports
Bioinformatics Market by Product and Geography - Forecast and Analysis 2022-2026
DNA Sequencing Market by Solution and Geography - Forecast and Analysis 2022-2026
Direct-To-Consumer Genetic Testing Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 16.37% |
Market growth 2021-2025 |
USD 1.38 billion |
Market structure |
Fragmented |
YoY growth (%) |
15.76 |
Regional analysis |
North America, Europe, Asia, ROW, North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, UK, Germany, France, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
23andMe Inc., Alpha Biolaboratories Ltd., Centrillion Technology Holdings Ltd., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., and Quest Diagnostics Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 01: Parent market
- Exhibit 02: Market characteristics
- Exhibit 03: Value chain analysis: Life Sciences Tools and Services
3 Market Sizing
- 3.1 Market definition
- Exhibit 05: Market segments
- 3.2 Market segment analysis
- 3.4 Market outlook: Forecast for 2020 - 2025
- Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
4 Five Forces Analysis
- 4.1 Bargaining power of buyers
- Exhibit 09: Bargaining power of buyers
- 4.2 Bargaining power of suppliers
- Exhibit 10: Bargaining power of suppliers
- Exhibit 11: Threat of new entrants
- 4.3 Threat of new entrants
- 4.4 Threat of substitutes
- Exhibit 12: Threat of substitutes
- 4.5 Threat of rivalry
- Exhibit 13: Threat of rivalry
- Exhibit 14: Market condition - Five forces 2020
5 Market Segmentation by Distribution channel
- 5.1 Market segments
- Exhibit 16: Comparison by Distribution channel
- 5.2 Comparison by Distribution channel
- Exhibit 17: Direct sales - Market size and forecast 2020-2025 ($ million)
- 5.3 Direct sales - Market size and forecast 2020-2025
- Exhibit 18: Direct sales - Year-over-year growth 2020-2025 (%)
- Exhibit 19: Retail sales - Market size and forecast 2020-2025 ($ million)
- 5.4 Retail sales - Market size and forecast 2020-2025
- Exhibit 20: Retail sales - Year-over-year growth 2020-2025 (%)
- Exhibit 21: Market opportunity by Distribution channel
- 5.5 Market opportunity by Distribution channel
6 Market Segmentation by Service
- 6.1 Market segments
- Exhibit 23: Comparison by Service
- 6.2 Comparison by Service
- Exhibit 24: Diagnostic screening - Market size and forecast 2020-2025 ($ million)
- 6.3 Diagnostic screening - Market size and forecast 2020-2025
- Exhibit 25: Diagnostic screening - Year-over-year growth 2020-2025 (%)
- Exhibit 26: Prenatal, newborn screening, and pre-implantation diagnosis - Market size and forecast 2020-2025 ($ million)
- 6.4 Prenatal, newborn screening, and pre-implantation diagnosis - Market size and forecast 2020-2025
- Exhibit 27: Prenatal, newborn screening, and pre-implantation diagnosis - Year-over-year growth 2020-2025 (%)
- Exhibit 28: Relationship testing - Market size and forecast 2020-2025 ($ million)
- 6.5 Relationship testing - Market size and forecast 2020-2025
- Exhibit 29: Relationship testing - Year-over-year growth 2020-2025 (%)
- Exhibit 30: Market opportunity by Service
- 6.6 Market opportunity by Service
7 Customer landscape
8 Geographic Landscape
- 8.1 Geographic segmentation
- Exhibit 33: Geographic comparison
- 8.2 Geographic comparison
- Exhibit 34: North America - Market size and forecast 2020-2025 ($ million)
- 8.3 North America - Market size and forecast 2020-2025
- Exhibit 35: North America - Year-over-year growth 2020-2025 (%)
- Exhibit 36: Europe - Market size and forecast 2020-2025 ($ million)
- 8.4 Europe - Market size and forecast 2020-2025
- Exhibit 37: Europe - Year-over-year growth 2020-2025 (%)
- Exhibit 38: Asia - Market size and forecast 2020-2025 ($ million)
- 8.5 Asia - Market size and forecast 2020-2025
- Exhibit 39: Asia - Year-over-year growth 2020-2025 (%)
- Exhibit 40: ROW - Market size and forecast 2020-2025 ($ million)
- 8.6 ROW - Market size and forecast 2020-2025
- Exhibit 41: ROW - Year-over-year growth 2020-2025 (%)
- Exhibit 42: Key leading countries
- 8.7 Key leading countries
- 8.8 Market opportunity by geography
- Exhibit 43: Market opportunity by geography ($ million)
9 Drivers, Challenges, and Trends
- 9.2 Market challenges
- Exhibit 45: Impact of drivers and challenges
10 Vendor Landscape
- 10.1 Overview
- Exhibit 47: Landscape disruption
- 10.2 Landscape disruption
11 Vendor Analysis
- 11.2 Market positioning of vendors
- Exhibit 50: Market positioning of vendors
- Exhibit 51: 23andMe Inc. - Overview
- Exhibit 52: 23andMe Inc. - Product and service
- Exhibit 53: 23andMe Inc. - Key offerings
- 11.3 23andMe Inc.
- Exhibit 54: Alpha Biolaboratories Ltd. - Overview
- Exhibit 55: Alpha Biolaboratories Ltd. - Product and service
- 11.4 Alpha Biolaboratories Ltd.
- Exhibit 56: Alpha Biolaboratories Ltd. - Key offerings
- Exhibit 57: Centrillion Technology Holdings Ltd. - Overview
- Exhibit 58: Centrillion Technology Holdings Ltd. - Product and service
- Exhibit 59: Centrillion Technology Holdings Ltd. - Key offerings
- 11.5 Centrillion Technology Holdings Ltd.
- Exhibit 60: Color Genomics Inc. - Overview
- Exhibit 61: Color Genomics Inc. - Product and service
- 11.6 Color Genomics Inc.
- Exhibit 62: Color Genomics Inc. - Key offerings
- Exhibit 63: Dante Labs Inc. - Overview
- Exhibit 64: Dante Labs Inc. - Product and service
- Exhibit 65: Dante Labs Inc. - Key offerings
- 11.7 Dante Labs Inc.
- Exhibit 66: DNA Diagnostic Center Inc. - Overview
- Exhibit 67: DNA Diagnostic Center Inc. - Product and service
- 11.8 DNA Diagnostic Center Inc.
- Exhibit 68: DNA Diagnostic Center Inc. - Key offerings
- Exhibit 69: Full Genomes Corp. - Overview
- Exhibit 70: Full Genomes Corp. - Product and service
- Exhibit 71: Full Genomes Corp. - Key offerings
- 11.9 Full Genomes Corp.
- Exhibit 72: Laboratory Corp. of America Holdings - Overview
- Exhibit 73: Laboratory Corp. of America Holdings - Business segments
- 11.10 Laboratory Corp. of America Holdings
- Exhibit 74: Laboratory Corp. of America Holdings - Key offerings
- Exhibit 75: Laboratory Corp. of America Holdings - Segment focus
- Exhibit 76: Myriad Genetics Inc. - Overview
- Exhibit 77: Myriad Genetics Inc. - Business segments
- 11.11 Myriad Genetics Inc.
- Exhibit 78: Myriad Genetics Inc. - Key news
- Exhibit 79: Myriad Genetics Inc. - Key offerings
- Exhibit 80: Myriad Genetics Inc. - Segment focus
- Exhibit 81: Quest Diagnostics Inc. - Overview
- Exhibit 82: Quest Diagnostics Inc. - Business segments
- Exhibit 83: Quest Diagnostics Inc. - Key offerings
- 11.12 Quest Diagnostics Inc.
- Exhibit 84: Quest Diagnostics Inc. - Segment focus
12 Appendix
- 12.1 Scope of the report
- Exhibit 85: Currency conversion rates for US$
- 12.2 Currency conversion rates for US$
- Exhibit 86: Research Methodology
- 12.3 Research methodology
- Exhibit 87: Validation techniques employed for market sizing
- Exhibit 88: Information sources
- Exhibit 89: List of abbreviations
- 12.4 List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article